GMAB technical analysis
GMAB Technical Analysis
Analysis date
July 18, 2026
Market
NasdaqGS (USD)
Daily cutoff
July 17, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
GMAB Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- GMAB
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- July 17, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Financial Modeling Prep (FMP) | 28.97 | July 17, 2026 | - | Verified |
| Massive API (independent) | 28.97 | July 17, 2026 | 0.00% | Verified |
Bottom line
GMAB Technical Analysis Summary
GMAB (Genmab A/S) shows a constructive technical picture with the stock trading above all major moving averages on the daily chart. At 28.97, price is above SMA20 (27.52, +5.27%), SMA50 (26.85, +7.90%), and SMA200 (25.43, +13.92%), indicating a well-established uptrend across all timeframes. RSI14 at 60.82 on the daily chart reflects bullish momentum without approaching overbought territory. The daily MACD shows a bullish configuration with the MACD line at 0.37 above the signal line at 0.18, and the histogram at 0.19 is solidly positive. The weekly timeframe confirms the constructive picture with price above SMA20 (27.41) and SMA50 (26.12) but still below SMA200 (28.18), though the gap is narrowing. Weekly RSI at 57.12 shows steady bullish momentum. Key resistance lies at the 52-week high of 34.08. Support rests at SMA20 (27.52) and the 20-day low of 25.81. The overall technical setup favors the bullish bias as long as price holds above the rising SMA20.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 17, 2026)
- Trend
- Bullish. Price at 28.97 is above SMA20 (27.52, +5.27%), SMA50 (26.85, +7.90%), and SMA200 (25.43, +13.92%). All three moving averages are sloping upward in a bullish alignment, with SMA20 above SMA50 above SMA200 — a classic golden cross formation that supports sustained upward momentum.
- Momentum
- Bullish. RSI14 at 60.82 is firmly above the 50 midline, indicating healthy bullish momentum without overbought conditions. MACD line at 0.37 is above the signal line at 0.18, and the histogram at 0.19 is positive. The MACD has been in positive territory since late May 2026, reflecting sustained buying pressure.
- Volatility
- Moderate. ATR14 at 0.68 (2.35% of price) suggests typical daily movement of about 2-2.5%. Bollinger Bands (25.82 to 30.02) show price oscillating near the upper half of the band, consistent with the uptrend. Band width is moderate, indicating normal volatility conditions for a biotech stock.
- Volume
- Moderate. Latest volume is near the 20-period average, indicating balanced participation. No unusual volume spikes or divergences that would suggest exhaustion. The steady volume profile supports the sustainability of the current trend.
Assessment
The daily chart presents a clean bullish picture. GMAB has established a well-defined uptrend with supportive momentum indicators. The golden cross formation (SMA20 above SMA50 above SMA200) is a technically meaningful bullish signal. RSI at 60.82 provides room for further upside before reaching overbought levels. The MACD remains in a sustained bullish phase. The stock is trading at 52.6% of its 52-week range, suggesting there is room for further upside toward the 52-week high of 34.08.
Weekly (July 13, 2026 week)
- Trend
- Improving bullish. Price at 28.82 is above SMA20 (27.41) and SMA50 (26.12) but slightly below SMA200 (28.18) by about 2.3%. The SMA20 is sloping upward and has crossed above SMA50, creating a bullish alignment. The weekly SMA200 is flattening, suggesting the longer-term trend is transitioning from neutral to bullish.
- Momentum
- Bullish. RSI14 at 57.12 is above the 50 midline, consistent with a gradual uptrend. MACD line at 0.42 is above the signal line at 0.11, and the histogram at 0.31 is positive and expanding, indicating strengthening bullish momentum at the weekly level. The MACD has been in a bullish crossover since early June 2026.
- Volatility
- Moderate. ATR14 at 1.52 (5.27% of price) reflects typical weekly ranges for a mid-cap biotech stock. Bollinger Bands (24.60 to 31.50) show price in the upper half of the band, consistent with the uptrend.
- Volume
- Near average. Weekly volume is approximately 92% of the 20-week average, indicating normal participation levels. No concerning divergences between price and volume.
Assessment
The weekly chart supports the bullish narrative established by the daily timeframe. Price has reclaimed SMA20 and SMA50, and the golden cross between SMA20 and SMA50 on the weekly chart is a positive development. SMA200 at 28.18 is the final hurdle for a fully bullish weekly picture — a weekly close above this level would be a meaningful technical milestone. The MACD is in a sustained bullish crossover with expanding histogram, providing confidence in the trend.
Key indicators
GMAB Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 60.82 | 57.12 |
| MACD (12, 26, 9) | 0.37 / 0.18 / 0.19 | 0.42 / 0.11 / 0.31 |
| ATR (14) | 0.68 (2.35%) | 1.52 (5.27%) |
| Bollinger Bands (20, 2) | 25.82 - 30.02 | 24.60 - 31.50 |
| SMA (20) | 27.52 | 27.41 |
| SMA (50) | 26.85 | 26.12 |
| SMA (200) | 25.43 | 28.18 |
Price structure
GMAB Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 28.97 | 28.82 |
| 1-Period Return | +0.73% | +1.87% |
| 5-Period Return | +2.62% | +3.44% |
| 20-Period Return | +6.70% | +8.14% |
| 60-Period Return | +14.05% | +16.52% |
| 252-Period Return | +13.22% | +10.40% |
| 52-Week Low | 22.54 | 22.54 |
| 52-Week High | 34.08 | 34.08 |
| 52-Week Position | 52.60% | 50.26% |
Key levels
GMAB Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 29.85 | 31.02 |
| 20-Period Low | 25.81 | 24.85 |
| 60-Period High | 30.55 | 34.08 |
| 60-Period Low | 22.54 | 22.54 |
Scenarios
GMAB Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish Continuation
Trigger
Price holds above SMA20 (27.52) and continues to grind higher toward the 60-day high at 30.55 and eventually the 52-week high at 34.08.
Invalidation
A weekly close below SMA20 (27.41) on increasing volume would suggest the uptrend is stalling.
What to watch
Daily RSI maintaining above 55; MACD histogram continuing to expand; weekly RSI climbing above 60; volume confirming break attempts above 30.00.
Pullback Within Uptrend
Trigger
Price pulls back to test SMA20 (27.52) or SMA50 (26.85) support levels, which is normal within a healthy uptrend.
Invalidation
Price breaks below SMA50 (26.85) and the 20-day low of 25.81, suggesting a deeper correction.
What to watch
Support at SMA20 holding on a daily close basis; RSI finding support near 50; volume contracting on pullback days; MACD histogram turning down but staying positive.
Bearish Reversal
Trigger
Price fails to hold SMA50 (26.85) and breaks below the 20-day low of 25.81 with above-average volume, potentially reversing the uptrend.
Invalidation
Price reclaims SMA20 (27.52) and makes a higher high above 29.85, negating the bearish setup.
What to watch
Daily RSI falling below 50; MACD histogram turning negative; weekly RSI dropping below 50; increasing volume on down days; a weekly close below SMA20 (27.41).
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Financial Modeling Prep (FMP, primary) and Massive API (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 17, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 13, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 17, 2026, weekly July 13, 2026 week. Generated July 18, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.